You are here

Article Text

Article menu
Download PDFPDF
Letter
The potential role of testosterone in central serous chorioretinopathy
  1. M C Grieshaber1,
  2. J-J Staub2,
  3. J Flammer3
  1. 1Department of Ophthalmology, University Hospital, Basle, Switzerland
  2. 2Division of Endocrinology, Department of Internal Medicine, University Hospital, Basle, Switzerland
  3. 3Department of Ophthalmology, University Hospital, Basle, Switzerland
  1. Correspondence to: Dr M C Grieshaber Department of Ophthalmology, University Hospital Basle, Mittlere Strasse 91, PO Box, CH-4031 Basle, Switzerland; mgrieshaber{at}uhbs.ch

https://doi.org/10.1136/bjo.2006.098277

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Risk factors for central serous chorioretinopathy (CSCR) are male gender, psychological stress, type-A personality, corticoid–steroid treatment and pregnancy. The reason for the presence of male gender as a risk factor is not yet clear. One possibility is a direct influence of androgens. We report a case of a female patient who developed CSCR under testosterone treatment.

    Case report

    A 45-year-old non-pregnant woman presented with a 1-day history of metamorphopsia and scotoma in the right eye. She had no eye problems in the past, but her current profession as a manager exposed her to several stress situations. On examination of the right eye, the best-corrected visual acuity (BCVA) was 20/25; paracentral scotoma and metamorphopsia were confirmed …

    View Full Text

    Footnotes

    • Competing interests: None.